1. Academic Validation
  2. DHHC5 facilitates oligodendrocyte development by palmitoylating and activating STAT3

DHHC5 facilitates oligodendrocyte development by palmitoylating and activating STAT3

  • Glia. 2022 Feb;70(2):379-392. doi: 10.1002/glia.24113.
Yanchen Ma 1 Huiqing Liu 1 Zhimin Ou 1 Chen Qi 1 Rui Xing 1 Shiyun Wang 1 Yinuo Han 1 Tong-Jin Zhao 2 Ying Chen 1
Affiliations

Affiliations

  • 1 State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, China.
  • 2 Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Zhongshan Hospital, Fudan University, Shanghai, China.
Abstract

Myelin sheath is an important structure to maintain functions of the nerves in central nervous system. Protein palmitoylation has been established as a sorting determinant for the transport of myelin-forming proteins to the myelin membrane, however, its function in the regulation of oligodendrocyte development remains unknown. Here, we show that an Asp-His-His-Cys (DHHC) motif-containing palmitoyl acyltransferases, DHHC5, is involved in the control of oligodendrocyte development. Loss of Zdhhc5 in oligodendrocytes inhibits myelination and remyelination by reducing total myelinating oligodendrocyte population. STAT3 is the primary substrate for DHHC5 palmitoylation in oligodendrocytes. Zdhhc5 ablation reduces STAT3 palmitoylation and suppresses STAT3 phosphorylation and activation. As a result, the transcription of the myelin-related and anti-apoptosis genes is inhibited, leading to suppressed oligodendrocyte development and myelination. Our findings demonstrate a key role DHHC5 in controlling myelinogenesis.

Figures
Products